Clopidogrel with aspirin is the optimal antiplatelet regimen for intracoronary stenting

J Thromb Thrombolysis. 1999 Jun;7(3):227-31. doi: 10.1023/a:1008981408216.
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Angioplasty, Balloon, Coronary*
  • Aspirin / administration & dosage
  • Aspirin / adverse effects
  • Aspirin / therapeutic use*
  • Clinical Trials as Topic
  • Clopidogrel
  • Coronary Disease / therapy*
  • Coronary Thrombosis / prevention & control*
  • Drug Therapy, Combination
  • Hematologic Diseases / chemically induced
  • Humans
  • Platelet Aggregation Inhibitors / administration & dosage
  • Platelet Aggregation Inhibitors / adverse effects
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Premedication
  • Randomized Controlled Trials as Topic
  • Stents*
  • Ticlopidine / administration & dosage
  • Ticlopidine / adverse effects
  • Ticlopidine / analogs & derivatives*
  • Ticlopidine / therapeutic use

Substances

  • Platelet Aggregation Inhibitors
  • Clopidogrel
  • Ticlopidine
  • Aspirin